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Background: The hypothalamus has an important role in the onset and maintenance of hypertension and stress
responses. Rats with inherited stress-induced arterial hypertension (ISIAH), reproducing the human stress-sensitive
hypertensive state with predominant involvement of the neuroendocrine hypothalamic-pituitary-adrenal and
sympathoadrenal axes, were used for analysis of the hypothalamus transcriptome.
Results: RNA-seq analysis revealed 139 genes differentially expressed in the hypothalami of hypertensive ISIAH and
normotensive Wistar Albino Glaxo (WAG) rats. According to the annotation in databases, 18 of the differentially expressed
genes (DEGs) were associated with arterial hypertension. The Gene Ontology (GO) functional annotation showed that
these genes were related to different biological processes that may contribute to the hypertension development in the
ISIAH rats. The most significantly affected processes were the following: regulation of hormone levels, immune system
process, regulation of response to stimulus, blood circulation, response to stress, response to hormone stimulus, transport,
metabolic processes, and endocrine system development. The most significantly affected metabolic pathways were those
associated with the function of the immune system and cell adhesion molecules and the metabolism of retinol and
arachidonic acid. Of the top 40 DEGs making the greatest contribution to the interstrain differences, there were 3
genes (Ephx2, Cst3 and Ltbp2) associated with hypertension that were considered to be suitable for further studies as
potential targets for the stress-sensitive hypertension therapy. Seven DEGs were found to be common between
hypothalamic transcriptomes of ISIAH rats and Schlager mice with established neurogenic hypertension.
Conclusions: The results of this study revealed multiple DEGs and possible mechanisms specifying the hypothalamic
function in the hypertensive ISIAH rats. These results provide a basis for further investigation of the signalling
mechanisms that affect hypothalamic output related to stress-sensitive hypertension development.
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Brain regulatory mechanisms play a major role in the
control of sympathetic outflow and blood pressure (BP)
regulation [1]. Based on the review of many studies, it
was noted that most forms of hypertension are associ-
ated with a wide variety of functional changes in the
hypothalamus [2]. In recent studies, progress has been* Correspondence: oredina@ngs.ru
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mination of global alterations in gene expression in key
brain regions of animal models of neurogenic hyperten-
sion [3]. However, ongoing novel approaches and studies
on different animal models are expected to lead to the
identification of genes that serve as a common link be-
tween different forms of the disease [4] and a better un-
derstanding of the processes responsible for the
increased sympathetic outflow and hypertension devel-
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As the studies on experimental animal models provide
valuable information to elucidate the nature of polygenic
traits [5], a number of animal models for essential
hypertension are widely used. One of these is the ISIAH
(Inherited Stress-Induced Arterial Hypertension) rat strain,
which has been developed to study the mechanisms of
stress-sensitive hypertension and its complications. The
ISIAH rat strain was selected from outbred normotensive
Wistar rats for an increased BP response to emotional
stress caused by 30 min restraint in a cylindrical wire-mesh
cell. The current population of ISIAH rats is characterized
by elevation of both the basal arterial BP, which reaches up
to 175.0 ± 3.5 mmHg in males and 165.0 ± 3.0 mmHg in
females, and the stress-induced BP, which increases just
after the mild emotional stress up to 195.0 ± 2.4 mmHg in
males and 174.0 ± 3.2 mmHg in females [6, 7]. The high
genetic homogeneity of the ISIAH strain was demonstrated
by a DNA fingerprinting procedure using a multilocus
microsatellite (CAC)5 probe [8]. Earlier studies showed that
the ISIAH rats may be regarded as a model for the human
stress sensitive hypertensive disease with predominant
involvement of the neuroendocrine hypothalamic-pituitary-
adrenal (HPA) and sympathoadrenal systems in the patho-
genesis of the hypertensive state [9].
The recently developed next-generation sequencing
technologies, widely used for transcriptome analysis (RNA-
Seq approach), are making substantial contributions to the
understanding of genome-wide expression and regulation
[10]. In the current work, RNA-Seq technology was used
for comparative analysis of the hypothalamic transcriptome
in hypertensive ISIAH and inbred normotensive WAG rats.
The goal of the study was to identify the differentially
expressed genes (DEGs) and pathways involved in the
differences of hypothalamic functions in the hypertensive
ISIAH and normotensive WAG rats.
The study revealed multiple DEGs in the hypothalami
of hypertensive ISIAH and normotensive WAG rats,
including 18 DEGs known to be related to hypertension
and the regulation of BP. These DEGs were associated
with a diverse group of biological processes and pathways.
Three DEGs were in the list of the top 40 DEGs defined
as genes making the largest contribution to inter-strain
differences. These DEGs may be considered potential
candidates for further studies to better understand the
mechanisms of hypertension development in ISIAH rats.
Results
Altogether, 11,369 annotated genes were defined as being
expressed in the hypothalami of ISIAH and WAG rats and
were used in comparative expression analysis, which
revealed 139 DEGs. For a complete listing of these results,
see Additional file 1. The hierarchical clustering using
Euclidean distance is shown in Fig. 1. About half of theDEGs (71 genes, i.e., 51.1 %) were down-regulated in ISIAH
rats. Two of the DEGs, Ahsp (alpha haemoglobin stabilizing
protein, 1.9 FPKM) and RGD1359290 (ribosomal_L22
domain containing protein, 46.5 FPKM), were detected in
the hypothalamus of ISIAH rats but not in WAG rats.Functional annotation of DEGs
The most significant GO terms for biological processes,
which may be related to the hypertensive state of ISIAH
rats, and genes in related groups of DEGs are repre-
sented in Additional file 2. The major DEG groups were
associated with the regulation of hormone levels, im-
mune system processes, blood circulation, response to
stimulus and regulation of the response to stimulus,
transport, metabolic process, gland development, and
regulation of the immune response. Some of these
groups consisted of several subgroups describing the
specificity of the processes. For instance, the group of
DEGs associated with blood circulation included 5 genes
that participate in the regulation of BP. The group la-
belled, ‘response to stimulus’, consisted of several sub-
groups based on the specificity of the stimuli. These
subgroups predominantly consisted of ‘response to
stress’, ‘response to hormone stimulus’, ‘response to inor-
ganic substance’, and ‘response to external stimulus’.
Many DEGs were associated with different metabolic
processes including lipid metabolism, hormone metabol-
ism, and vitamin A and catecholamine metabolic pro-
cesses. These and some other DEG groups related to
immune system processes, oxidation reduction, endo-
crine system development, cell activation and prolifera-
tion, indicated that there were multiple impairments in
hypothalamic functions in hypertensive rats.
Two DEGs known to be key players in corticosteroid
biosynthesis and BP regulation (Cyp11b1 and Cyp11b2)
were estimated to be up-regulated in the hypothalamus of
hypertensive ISIAH rats. However, these genes were
merged during the Cufflinks assembly and thus were tested
as a single unit by the Cuffdiff program. To distinguish
between their levels of expression, we performed quantita-
tive real time polymerase chain reaction (qPCR). The
results of qPCR confirmed the enhanced expression of
both the Cyp11b1 and Cyp11b2 genes in the hypothalamus
of ISIAH rats (Fig. 2).
The analysis in the Kyoto Encyclopedia of Genes and
Genomes Pathway Database (KEGG) showed that the
inter-strain differences in gene expression are related to
six pathways that were significantly enriched (p < 0.05;
Additional file 3). Four of these pathways were associ-
ated with the function of the immune system. All of the
pathways (except for retinol metabolism) contained
genes associated with hypertension and with central ner-
vous system (CNS) diseases.
Fig. 1 Heatmap of the differentially expressed genes in the hypothalami of the ISIAH and WAG rats. Dendrograms were constructed using
hierarchical ‘complete linkage’ clustering by Euclidean distance. Yellow depicts genes that were up-regulated in a sample, and red depicts those
that were down-regulated
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Fig. 2 The relative mRNA abundance measured by qPCR. The relative mRNA abundance was calculated as the ratio of normalized (mRNA/Rpl30)
mRNA level in experimental ISIAH samples to normalized (mRNA/Rpl30) mRNA level in control WAG samples. The normalized mRNA level in
control samples of the WAG rats was assigned a value of 1. Vertical bars show the standard error of the mean, and significance of inter-strain
difference is indicated by *p < 0.05, **p < 0.01, ***p < 0.001
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Of the genes found to be differentially expressed in
the hypothalami of ISIAH and WAG rats, 16 genes
are annotated in the Rat Genome Database (RGD) as
associated with hypertension, and two additional
DEGs (P2rx4, and Sult1a1) were related to the regu-
lation of BP according to the Database for Annota-
tion, Visualization and Integrated Discovery (DAVID)
tool. These 18 genes might be essential for hyperten-
sion development in ISIAH rats. Most of these genes
are annotated in RGD as associated with diseases
concomitant to hypertension, such as insulin resist-
ance and CNS diseases (Table 1). Altogether, we
found 26 DEGs referred to in RGD as associated with
CNS diseases, including cerebrovascular disorders,
brain infarction, and brain ischemia. Many of these
genes were also related to immune system diseases
(Table 2).Transcription factors
Five transcription factor genes were differentially
expressed in ISIAH and WAG hypothalami (Table 3).
One of these (Ercc2) is annotated in RGD as being
associated with hypertension. According to the GO
functional annotation, two genes (Ercc2 and Grhl3)
were associated with response to stress, and three
genes (Foxg1, Mcm7, and Pitx1) were related to meta-
bolic processes. Moreover, Pitx1 was related to the
GO term ‘endocrine system development’ (Additional
file 2).Genes making the greatest contribution to the inter-
strain differences
The partial-least squares discriminant analysis (PLS-DA)
was used to detect the genes that made the greatest con-
tribution to the inter-strain differences. The PLS-DA
Axes maximizing the distances between ISIAH and
WAG rats were constructed (Additional file 4), and the
correlation between gene expression and PLS-DA Axis 1
was defined. The genes that were designated as differen-
tially expressed are shown in red in Figure in Additional
file 5, and their polar position along the first PLS-DA
Axis confirms their contribution to the existing inter-
strain variations.
The top 40 DEGs that make the most significant con-
tribution to the inter-strain differences possess different
biological potencies (Table 4). According to RGD anno-
tations, there were several genes related to CNS diseases
(Abcg2, Ephx2, RGD1563482, Tgfb2, Mal, and Cst3), and
3 genes associated with hypertension (Ephx2, Cst3, and
Ltbp2) are found on this list. These 3 genes may be con-
sidered to be potential candidates for further studies to
better understand the mechanisms of hypertension de-
velopment in ISIAH rats. Their differential transcription
was validated by qPCR (Fig. 2). The comparison of the
relative mRNA abundance is shown in Additional file 6.
The correlation coefficient between the results from the
two methods was 0.98.
Discussion
Mapping and quantifying mammalian transcriptomes by
deep sequencing (RNA-Seq) provides a digital measure
Table 1 Genes differentially expressed in ISIAH and WAG hypothalami and referred to in Databases as associated with hypertension
and blood pressure regulation
Gene symbol Acc.# Gene name log2 fold_change ISIAH/WAG
Rat Genome Database
Chi3l1a,b NM_053560 chitinase 3-like 1 (cartilage glycoprotein-39) −1.27
Cst3a,c,b NM_012837 cystatin C −0.59
Cyp11b1 NM_012537 cytochrome P450, family 11, subfamily b, polypeptide 1 1.06
Cyp11b2a,c,b NM_012538 cytochrome P450, family 11, subfamily b, polypeptide 2 1.06
Ephx2a,c,b NM_022936 epoxide hydrolase 2, cytoplasmic 4.40
Fn1a NM_019143 no definition) −0.98
Gstm2 NM_177426 glutathione S-transferase mu 2 −0.74
Hyal1 NM_207616 hyaluronoglucosaminidase 1 0.71
Igfbp2a,c NM_013122 insulin-like growth factor binding protein 2 −0.92
Ltbp2 NM_021586 latent transforming growth factor beta binding protein 2 −2.88
Prkcda,c,b NM_133307 protein kinase C, delta 0.63
Ptgdsa,c,b NM_013015 prostaglandin D2 synthase (brain) −0.57
RT1-Baa,b NM_001008831 RT1 class II, locus Ba −0.80
RT1-Bba,b NM_001004084 RT1 class II, locus Bb −1.26
RT1-Db1a,b NM_001008884 RT1 class II, locus Db1 −0.76
Slc6a3a NM_012694 solute carrier family 6 (neurotransmitter transporter), member 3 −1.34
DAVID
P2rx4 NM_031594 purinergic receptor P2X, ligand-gated ion channel 4 −0.86
Sult1a1 NM_031834 sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 −0.63
Genes associated with: a- central nervous system diseases; b- cerebrovascular disorders; c- insulin resistance; ISIAH and WAG – rat strains used in the study.
DAVID - Database for Annotation, Visualization and Integrated Discovery
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current study, an RNA-Seq approach was performed to
detect genes with altered transcriptional activity in the
hypothalamus of hypertensive ISIAH rats compared to
normotensive WAG rats. However, only 18 out of the
139 DEGs found in the current study were characterized
as being associated with the hypertension. This could be
explained by genetic drift during the selection process,
which could result in randomly fixed alleles contributing
to differences in gene expression but not related to dis-
ease itself. The functional annotation of DEGs helped to
define the main biological processes that might contrib-
ute to inter-strain differences. This analysis showed that
almost all GO groups contained the DEGs associated
with hypertension (see Additional file 2). These results
highlight once again that many genes and biological pro-
cesses may contribute to the stress-sensitive hyperten-
sion development.
As expected, GO annotation revealed multiple DEGs
related to the hormonal nature of hypothalamic func-
tion. The group of eight DEGs participating in the regu-
lation of hormone levels (see Additional file 2) might
play an important role in the orchestration of the
changes in physiological and metabolic processes in
ISIAH hypothalamus. This group contained severalgenes associated with hypertension. Two genes in this
group, cytochrome P450, family 11, subfamily b, poly-
peptide 1 (Cyp11b1) and cytochrome P450, family 11,
subfamily b, polypeptide 2 (Cyp11b2), are known to be
key players in steroidogenic pathways [12]. These genes
are particularly known to be involved in corticosterone
and aldosterone biosynthesis and are widely known to
be regulators of BP. It was shown that the small
amounts of aldosterone synthesized in the brain of Dahl
salt-sensitive hypertensive rats could provide a local lig-
and for autocrine or paracrine activation of the min-
eralocorticoid receptor [13], and this was important in
the genesis of salt-sensitive hypertension [14]. Aldoster-
one synthesized in the brain contributes to salt-sensitive
hypertension through an increased salt appetite, sympa-
thetic drive and vasopressin release [15]. The up-
regulation of the Cyp11b2 gene found in the current
study may result in aldosterone excess in the hypothal-
amus of ISIAH rats and may also contribute to the de-
velopment of stress-sensitive hypertension.
Several other DEGs participated in the regulation of
hormone levels were related to retinol metabolism: alde-
hyde dehydrogenase 1 family, member A2 (Aldh1a2),
cytochrome P450, family 26, subfamily b, polypeptide 1
(Cyp26b1), retinol binding protein 4, plasma (Rbp4), and
Table 2 Genes differentially expressed in ISIAH and WAG hypothalami and referred to in Rat Genome Database as associated with
central nervous system diseases
Gene symbol Acc.# Gene name log2 fold_change ISIAH/WAG
Abca1a NM_178095 ATP-binding cassette, subfamily A (ABC1), member 1 0.65
Abcg2 NM_181381 ATP-binding cassette, subfamily G (WHITE), member 2 1.83
Adamts4a,b,c NM_023959 ADAM metallopeptidase with thrombospondin type 1 motif, 4 −0.59
Chi3l1a,b NM_053560 chitinase 3-like 1 (cartilage glycoprotein-39) −1.27
Cst3a,b,c NM_012837 cystatin C −0.59
Ctssa,b NM_017320 cathepsin S −0.50
Cyp11b2b NM_012538 cytochrome P450, family 11, subfamily b, polypeptide 2 1.06
Ephx2b,d,c NM_022936 epoxide hydrolase 2, cytoplasmic 4.40
Ercc2 NM_001172809 excision repair cross-complementation group 2 2.30
Fn1a NM_019143 fibronectin 1 −0.98
Galc NM_001005888 galactosylceramidase −0.72
Igf2a,b,d,c NM_001190162 insulin-like growth factor 2 (Igf2), transcript variant 2 −1.09
Igfbp2 NM_013122 insulin-like growth factor binding protein 2 −0.92
Mal NM_012798 mal, T-cell differentiation protein −0.72
P2ry12a,b NM_022800 purinergic receptor P2Y, G-protein coupled, 12 0.59
Prkcda,b,c NM_133307 protein kinase C, delta 0.63
Ptgdsb NM_013015 prostaglandin D2 synthase (brain) −0.57
RGD1563482 NM_001109065 similar to hypothetical protein FLJ38663 0.79
RT1-Baa,b,d,c NM_001008831 RT1 class II, locus Ba −0.80
RT1-Bba,b NM_001004084 RT1 class II, locus Bb −1.26
RT1-Daa NM_001008847 RT1 class II, locus Da −0.63
RT1-Db1a,b NM_001008884 RT1 class II, locus Db1 −0.76
Selplgb NM_001013230 selectin P ligand −0.78
Slc6a3 NM_012694 solute carrier family 6 (neurotransmitter transporter), member 3 −1.34
Tgfb2a NM_031131 transforming growth factor, beta 2 0.85
Vtna NM_019156 vitronectin −0.56
Genes associated with: a- immune system diseases; b- cerebrovascular disorders; c- brain ischemia; d- brain infarction; ISIAH and WAG – rat strains used in
the study
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tial signalling molecule. In the adult brain, RA has been
shown to be involved in synaptic plasticity, the induction
of neural differentiation, motor axon outgrowth and
nerve regeneration [16, 17]. In the current study, Rbp4
and RetSat were in a list of the top 40 DEGs that con-
tribute the most to inter-strain differences (Table 4).
Additionally, in this list, there was one additional gene,Table 3 Transcription factor genes differentially expressed in ISIAH a
Gene symbol Acc.# Gene name
Ercc2 NM_001172809 excision repair cross-co
Foxg1 NM_012560 forkhead box G1
Grhl3 NM_001106690 grainyhead-like 3 (Droso
Pitx1 NM_053624 paired-like homeodoma
Mcm7 NM_001004203 minichromosome main
ISIAH and WAG – rat strains used in the studystimulated by retinoic acid 6 (Stra6), related to retinol
transport across the cell membrane [18]. These data sug-
gest that retinol metabolism is likely to make a substantial
contribution to inter-strain differences in hypothalamic
functions; however, the direct influence of this pathway to
BP regulation has not been defined so far.
One additional gene associated with the regulation of
hormone level was Cga (glycoprotein hormones, alphand WAG hypothalami
log2 fold_change ISIAH/WAG




tenance complex component 7 1.06
Table 4 The top 40 differentially expressed genes making the greatest contribution to the inter-strain differences in hypothalamic
function of ISIAH and WAG rats
Gene
symbol
Acc.# Correlation log2 (fold_change)
ISIAH/WAG
Definition Function and/or process
Retsat NM_145084 0.998 1.82 retinol saturase (all trans retinol
13,14 reductase)
oxidoreductase activity [64]
Sc5d NM_053642 0.997 1.21 sterol-C5-desaturase cholesterol biosynthetic process via
lathosterol [65] fatty acid metabolic
process; lathosterol oxidase
activity [66]
RGD1359290 NM_001047898 0.996 was detected in ISIAH
but not in WAG
Ribosomal_L22 domain containing
protein RGD1359290
structural constituent of ribosome
Abcg2a NM_181381 0.994 1.83 ATP-binding cassette, subfamily
G (WHITE), member 2
transmembrane transport [67]
Ephx2a,b NM_022936 0.993 4.40 epoxide hydrolase 2, cytoplasmic positive regulation of blood pressure [24]
Fam111a NM_001109163 0.993 5.12 family with sequence similarity
111, member A
DNA replication [68]
RGD1563482a NM_001109065 0.990 0.79 similar to hypothetical protein
FLJ38663
aminoacyl-tRNA hydrolase activity
Stra6 NM_001029924 0.990 0.70 stimulated by retinoic acid 6 transports retinol across the cell
membrane [18]
Aox2 NM_001008522 0.985 1.47 aldehyde oxidase 2 oxidoreductase activity
Fhit NM_021774 0.983 1.46 fragile histidine triad nucleotide metabolic process [69]
Tekt4 NM_001013965 0.981 1.00 tektin 4 protein binding [70]
LOC689064 NM_001111269 0.980 3.23 beta-globin oxygen transporter activity
Grhl3 NM_001106690 0.976 1.37 grainyhead-like 3 (Drosophila) may stimulate migration of endothelial
cells [71]
Acad9 NM_181768 0.975 0.59 acyl-CoA dehydrogenase family,
member 9
oxidoreductase activity catalyze the
rate-limiting step in the beta-oxidation
of fatty acyl-CoA
Tgfb2a NM_031131 0.975 0.85 transforming growth factor,
beta 2
promotes the survival of dopaminergic
neurons [37]
Spg7 NM_181388 0.975 0.58 spastic paraplegia 7 homolog
(human)
metalloendopeptidase activity [72] nervous
system development [73]
Idnk NM_001037362 0.974 0.91 idnK, gluconokinase homolog
(E, coli)
gluconokinase activity
Lyz2 NM_012771 −0.968 −0.68 lysozyme 2 lysozyme activity
Mala NM_012798 −0.971 −0.72 mal, T-cell differentiation protein myelination [74]; structural constituent of
myelin sheath [75]
Lcat NM_017024 −0.972 −0.77 lecithin cholesterol acyltransferase phospholipase A2 activity [76] cholesterol
metabolic process [77]
PCOLCE2 NM_001127640 −0.972 −2.12 procollagen C-endopeptidase
enhancer 2
collagen binding [78]
RT1-S3 NM_001008886 −0.974 −2.03 RT1 class Ib, locus S3 antigen processing and presentation of
peptide antigen via MHC class I
Cst3a,b NM_012837 −0.976 −0.59 cystatin C prevents oxidative stress-induced death
[44]
Cyp2j10 NM_001134980 −0.977 −0.94 cytochrome P450, family 2,
subfamily j, polypeptide 10
EETs biosynthesis [79]
Gstm4 NM_001024304 −0.978 −1.75 glutathione S-transferase mu 4 glutathione binding glutathione metabolic
process
Grm2 NM_001105711 −0.979 −1.81 glutamate receptor, metabotropic
2
regulation of synaptic transmission,
glutamatergic [80]
Mx2 NM_134350 −0.979 −1.29 innate immune response [81]
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Table 4 The top 40 differentially expressed genes making the greatest contribution to the inter-strain differences in hypothalamic
function of ISIAH and WAG rats (Continued)
myxovirus (influenza virus)
resistance 2
Zfp385d NM_001013992 −0.980 −0.74 zinc finger protein 385D zinc ion binding
Tnnt1 NM_001277260 −0.981 −4.37 troponin T type 1 (skeletal, slow) regulation of muscle contraction [82]
Cpz NM_031766 −0.982 −0.89 carboxypeptidase Z zinc ion binding metallocarboxypeptidase
activity extracellular matrix homeostasis
Pyroxd2 NM_001004261 −0.983 −2.86 pyridine nucleotide-disulphide
oxidoreductase domain 2
oxidoreductase activity
Rbp4 NM_013162 −0.985 −1.49 retinol binding protein 4, plasma retinol transporter activity [83]
Abca8a NM_001281824 −0.987 −0.65 ATP-binding cassette, subfamily
A (ABC1), member 8a
transporter activity lipid transport
transmembrane transport
Mpeg1 NM_022617 −0.989 −2.31 macrophage expressed 1
Grifin NM_057187 −0.989 −4.44 galectin-related inter-fiber protein carbohydrate binding
Ltbp2b NM_021586 −0.989 −2.88 latent transforming growth factor
beta binding protein 2
decreases fibroblast adhesion to
fibronectin [84] negatively regulates
coalescence of oxytalan fibers induced
by stretching stress [85]
Snx14 NM_001108174 −0.990 −0.85 sorting nexin 14 phosphatidylinositol-3,5-bisphosphate
binding [86]
Pnpla1 NM_001191841 −0.993 −2.59 patatin-like phospholipase domain
containing 1
lipid catabolic process
RT1-A2 NM_001008829 −0.993 −1.98 RT1 class Ia, locus A2 antigen processing and presentation
of peptide antigen via MHC class I
RGD1309362 NM_001024884 −0.995 −2.46 similar to interferon-inducible
GTPase
Genes associated with: acentral nervous system diseases; b-hypertension; ISIAH and WAG – rat strains used in the study
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glycoprotein hormones: chorionic gonadotropin, luteinizing
hormone, follicle stimulating hormone, and thyroid stimu-
lating hormone. Its up-regulation in the ISIAH hypo-
thalamus may contribute to a variety of biological
processes related to endocrine system functioning in
hypertensive rats.
The Sult1a1 (sulfotransferase family, cytosolic, 1A,
phenol-preferring, member 1) gene was associated with
several biological processes including the regulation of
hormone levels, the regulation of BP, and the response
to hormone stimulus (Additional file 2). Rat sulfotrans-
ferase Sult1a1 catalyzes the sulfation of neurotransmit-
ters and xenobiotic phenolic compounds [19]. Sulfation
usually leads to the inactivation of biological signalling
molecules including catecholamines [20]. It was shown
that the experimental reduction of norepinephrine con-
tent in the anterior hypothalamus induced an increase in
arterial blood pressure and heart rate [21]. As Sult1a1
sulfates catecholamines, the down-regulation of this
gene in the ISIAH hypothalamus may be adaptive and
directed against the excessive elevation of BP.
Two other genes related to the regulation of the BP
level that are differentially expressed in ISIAH and
WAG hypothalami were the purinergic receptor P2X,the ligand-gated ion channel 4 (P2rx4) and epoxide
hydrolase 2, cytoplasmic (Ephx2). The product of the
P2rx4 gene belongs to the family of purinoceptors for
adenosine triphosphate. This receptor functions as a
ligand-gated cation-selective channel. Endothelial P2X4
channels regulate BP and vascular remodelling. P2rx4
has a key role in the response of endothelial cells to
changes in blood flow. P2rx4(−/−) mice have higher BP
levels and excrete smaller amounts of NO products in
their urine than wild-type mice [22]. Based on this, we
suggest that down-regulation of the P2rx4 gene in the
ISIAH hypothalamus might contribute to hypertension
development.
Ephx2 encodes the soluble epoxide hydrolase (sEH)
that metabolizes the epoxyeicosatrienoic acids (EETs).
EETs modulate ion transport and gene expression and
produce vasorelaxation, as well as anti-inflammatory and
pro-fibrinolytic effects [23]. sEH inhibition lowers arter-
ial BP in angiotensin II-induced hypertension [24]. sEH
overexpression was linked to hypertension in the spon-
taneously hypertensive rats [25]. Ephx2 was also consid-
ered to be one of the gatekeeper genes that contributes
to programmed hypertension [4]. In our study, Ephx2
was one of several DEGs related to arachidonic acid
(AA) metabolism. The two other DEGs, cytochrome
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cytochrome P450, family 4, subfamily x, polypeptide 1
(Cyp4x1), are also known to encode enzymes that regu-
late EET production. The down-regulation of these two
genes and the enhanced expression of the Ephx2 gene in
the ISIAH hypothalamus may lead to a reduced amount
of EETs and contribute to hypertension development in
ISIAH rats. In the current study, Ephx2 and Cyp2j10
were in a list of the top 40 DEGs that contribute the
most to inter-strain differences (Table 4).
One more DEG related to AA metabolism was prosta-
glandin D2 synthase (brain) (Ptgds). The decreased ex-
pression of Ptgds found in the current study may lead to
a reduced amount of prostaglandin D2, which is a major
brain prostaglandin that functions as a neuromodulator
and/or trophic factor in the CNS [26]. It is involved in
smooth muscle contraction/relaxation and is a potent
inhibitor of platelet aggregation [27].
Both GO annotation and KEGG analysis revealed
highly significant differences in the expression of genes
belonging to immune system processes in the hypothal-
ami of ISIAH and WAG rats. It is long known that im-
mune system changes play a role in hypertension and
that extensive bidirectional interactions between the
sympathetic nervous system and the immune system
exist [28, 29]. Recent studies have shown that both in-
nate and adaptive immunity contribute to hypertension
[30]. Major histocompatibility complex (MHC) class I
molecules are ligands for the killer-cell immunoglobulin-
like receptors that are expressed by natural killer (NK)
cells and T cells. The interactions between these mole-
cules contribute to both innate and adaptive immunity
[31]. MHC class-II molecules are key participants in im-
mune activation events in autoimmunity [32]. It was
shown that mice lacking adaptive immune cells, includ-
ing recombinase-activating gene-deficient mice and rats
and mice with severe combined immunodeficiency, have
blunted hypertension responses to stimuli such as ANG
II, high salt, and norepinephrine [33]. MHC molecules
are rare in healthy brain tissue, but are heavily expressed
on microglial cells after inflammatory or neurodegenera-
tive processes [34]. The transcription of most of the
DEGs that encode MHC molecules was decreased in the
hypothalamus of ISIAH rats. However, two genes, RT1-
A1 (RT1 class Ia, locus A1) and RT1-M3-1 (RT1 class Ib,
locus M3, gene 1), were up-regulated. Earlier, it was
shown that the expression of the RT1-A1 molecule pro-
tects targets from NK lysis [35]. In another study it was
found that the expression of RT1-A1 became up-
regulated in glial cells after mechanical nerve injury [36].
We can suppose that the elevated transcription of RT1-A1
in the ISIAH hypothalamus may play a protective role.
Altogether, there were three genes from the list of the
top 40 DEGs, RT1 class Ia, locus A2 (RT1-A2), RT1 classIb, locus S3 (RT1-S3), and transforming growth factor,
beta 2 (Tgfb2), that made the most significant contribu-
tion to the inter-strain differences in the group ‘im-
mune system process’ (Table 4). The possible role of
the MHC molecules in pathology development was dis-
cussed above. TGFb2 is known to promote the survival
of dopaminergic neurons [37]. The hypothalamic changes
in neurotransmitter and neuromodulator functions via the
sympathetic nervous system appear to play a predominant
role in most forms of hypertension [2]. Tgfb2 was one of
several DEGs identified in the current study that were re-
lated to endocrine system development (see Additional file
2). Two other genes related to this group and not dis-
cussed above were solute carrier family 6 (neurotrans-
mitter transporter), member 3 (Slc6a3) and paired-like
homeodomain 1 (Pitx1). The Slc6a3 gene encodes the
dopamine transporter. Its primary physiological role is
the regulation of extracellular dopamine by means of
rapid transport (reuptake) of dopamine back into the
dopaminergic presynaptic terminals. Increased expres-
sion of the dopamine transporter leads to a loss of
dopamine neurons and oxidative stress [38]. Therefore,
the up-regulation of Tgfb2 and the decreased expres-
sion of Slc6a3 found in the hypothalamus of ISIAH rats
might have a protective role for dopaminergic neurons.
Pitx1 encodes a homeobox transcription factor involved
in transcriptional activation of the pro-opiomelanocortin
(Pomc) gene [39, 40]. The increased hypothalamic POMC
presumably attenuates weight gain [41], activates sympa-
thetic neurotransmission to adipose tissues, accelerates
energy expenditure [42], and could be, at least in part, re-
sponsible for the increased sensitivity to insulin [43].
However, Pomc transcription was not significantly in-
creased in the ISIAH hypothalamus in our study. There-
fore, the up-regulation of Pitx1, may be essential for the
other signalling pathways in the hypothalamus of hyper-
tensive rats.
The hypothalamus is known as a brain region involved
in the regulation of body homeostasis and stress re-
sponses. In the current study, multiple DEGs were asso-
ciated with the response to different stimuli such as
stress, hormonal stimulus, inorganic substance, and ex-
ternal stimuli (Additional file 2). As the study was con-
ducted on rats not exposed to the stress, the DEGs in
the group ‘response to stress’ might be essential for
stress-sensitive hypertension development. Altogether,
we found nine genes (Cst3, Cyp11b2, Ephx2, Fn1, Igfbp2,
P2rx4, Prkcd, RT1-Ba, and Sult1a1) annotated in the
RGD as associated with hypertension in this group. Two
of these genes cystatin C (Cst3) and epoxide hydrolase 2,
cytoplasmic (Ephx2) were also present in the list of top
40 DEGs defined as making the largest contribution to
inter-strain differences (Table 4). Cystatin C (Cst3 gene)
is an inhibitor of cysteine proteinases. Expression of
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stresses that induce cell death [44]. The studies of hypo-
thalamic mechanisms underlying the neurogenic hyper-
tension in mice showed that inflammation and oxidative
stress via reactive oxygen species generation could con-
tribute to oxidative damage and activation of the sympa-
thetic nervous system leading to an increase in BP [45].
Therefore, the decreased transcription of the Cst3 gene
in the ISIAH hypothalamus may contribute to hyperten-
sion development as well as excessive transcription of
the Ephx2 gene discussed above.
Altogether, the group ‘response to stimulus’ contained
13 genes (Abcg2, Cst3, Ephx2, Grhl3, Grm2, Gstm4, Lcat,
Lyz2, Mx2, Rbp4, RT1-A2, RT1-S3, and Tgfb2) included
in the list of top 40 DEGs that contribute the most to
inter-strain differences in hypothalamic function in the
current study. The known activities of genes described
in Table 4 or discussed above underscore the diversity of
the mechanisms that contribute to the inter-strain differ-
ences. These genes might be useful in further studies to
elucidate the mechanisms accompanying the stress-
sensitive hypertension development.
In the current study, only 3 genes associated with
hypertension (Ephx2, Cst3 and Ltbp2) appeared on the
list of the top 40 DEGs that make the largest contribu-
tion to inter-strain differences. We suggest that these 3
genes might be of interest for their further studies as po-
tential therapeutic targets for stress-sensitive hyperten-
sion therapy. One of these genes, Ephx2, was already
proposed as a target for the treatment of hypertension
[46]. Ltbp2 had previously been proposed to be a po-
tential biomarker for atrial stress [47] and was pat-
ented as a biomarker for cardiovascular, hematological,
neurological, endocrinological, and urological diseases,
as well as cancer [48]. As discussed above, cystatin C
has protective effects against various oxidative stresses.
Therefore, its contribution to BP regulation may be
expected.
The analysis of different animal models of hyperten-
sion helps to identify the genes which may serve as a
common link between different forms of the disease [4].
In the current study, we found several common genes
with changed transcriptional activity in the hypothalami
of hypertensive ISIAH rats and hypertensive Schlager
mice that represent a genetic model of neurogenic
hypertension (Table 5) [45]. One of these genes, chitinase
3-like 1 (cartilage glycoprotein-39) (Chi3l1), is known to
be associated with hypertension. The protein encoded by
this gene is thought to play a role in the process of inflam-
mation [49], tissue remodelling [50] and reactive oxygen
species production [51]. The other genes listed in Table 5
were not previously related to the regulation of blood
pressure, but, as they are common between two models of
the disease, these genes may be considered promisingtargets for further studies directed to understanding the
processes contributing to increased sympathetic outflow
and hypertension development. During the last decade,
the results of high-throughput biological experiments
made a significant contribution to understanding the mo-
lecular bases of complex diseases. RNA-Seq is one of the
recently developed approaches to transcriptome profiling
which provides a far more precise measurement of levels
of transcripts than other methods [52]. However, it has
some limitations. The main limitation of RNA-Seq ana-
lysis is its expensiveness. The other limitation is the rela-
tive impossibility of technical validation of all the multiple
DEGs found in the experiment. Therefore, the current
study was conducted with the use of only three biological
replicates in both experimental and control groups, and
the expression of only several DEGs was validated technic-
ally. However, it was shown earlier that the results from
RNA-Seq analysis showed high levels of reproducibility
for both technical and biological replicates [53, 54]. In the
current study, we found a strong correlation (r = 0.98) be-
tween the qPCR and RNA-Seq data. These results are
similar to those reported by other groups [53].Conclusion
The results of comparative transcriptional profiling of
the hypothalamus in hypertensive ISIAH and normo-
tensive WAG rats helped to identify multiple DEGs,
including 18 genes associated with hypertension and
regulation of BP. These DEGs were related to the di-
versity of biological processes and pathways contrib-
uting significantly to the inter-strain differences
related to hypothalamic function. The discussion
demonstrated that many genes found to be differen-
tially expressed in ISIAH and WAG hypothalami
might be responsible for pathology development, and
that the changed expression of other genes may exert
compensatory effects and be directed toward the res-
toration of homeostasis. As the number of hyperten-
sive genes was considerable, we were not able to
discuss all of them in details. Moreover, the discus-
sion of some genes was complicated by uncertainty
about their roles, especially within the hypothalamus.
In the current study, we defined 3 genes associated
with hypertension (Ephx2, Cst3 and Ltbp2) that
might be of interest for further studies as potential
therapeutic targets for stress-sensitive hypertension
therapies. Our findings provide a basis for identifica-
tion of potential biomarkers of stress-sensitive hyper-
tension and for further investigation of the signalling
mechanisms that affect hypothalamic output related
to hypertension development and the resulting sym-
pathetic nervous system effects on other tissues and
the organism as a whole.
Table 5 The list of the common genes with changed transcriptional activity in hypothalami of hypertensive ISIAH rats and
hypertensive Schlager mice (26 weeks old), which represent a genetic model of neurogenic hypertension
Gene symbol Acc.# Gene definition log2 (fold_change) ISIAH/WAG Fold difference in Schlager miceb
Acer2 NM_001107943 alkaline ceramidase 2 0.60 1.69
Chi3l1a NM_053560 chitinase 3-like 1 (cartilage glycoprotein-39) −1.27 −1.73
Fhit NM_021774 fragile histidine triad 1.46 −1.3
Galc NM_001005888 galactosylceramidase −0.72 −1.42
Nkiras1 NM_001107252 NFKB inhibitor interacting Ras-like 1 0.59 1.19
Paqr5 NM_001014092 progestin and adipoQ receptor family member V 0.89 1.25
Tnnt1 NM_001277260 troponin T type 1 (skeletal, slow) −4.37 −2.01
a- Genes associated with hypertension; bValues represent mean of the fold difference between hypertensive and normotensive samples. Positive fold difference
values indicate higher expression in hypertension and negative fold difference values indicate higher expression in normotension [45]
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Animals
Two inbred rat strains were used in the current study.
Both hypertensive ISIAH (Inherited Stress Induced
Arterial Hypertension) and normotensive Wistar Albino
Glaxo (WAG/GSto-Icgn) rats were bred in the Center for
Genetic Resources of Laboratory Animals at the Institute
of Cytology and Genetics, Siberian Branch of the Russian
Academy of Sciences (Novosibirsk, Russia, RFME-
FI61914X0005 and RFMEFI61914X0010). All rats were
maintained under standard conditions with free access to
food and water. One week before the systolic arterial BP
measurement, animals were placed in individual cages.
The systolic arterial BP was measured indirectly by the
tail-cuff method under short-term ether anaesthesia to
exclude the effect of psychological stress induced by
the measuring procedure. In RNA-seq experiments, the
3-month-old ISIAH (n = 3) and WAG (n = 3) males
were used. Their systolic arterial BP was 171.7 ±
1.22 mmHg in ISIAH and 116.33 ± 1.86 mmHg in WAG
males. The rats were decapitated 6 days after BP measure-
ment, and their hypothalami were isolated according to
known anatomical location [55]. All samples were stored
in RNALater (Qiagen, Chatsworth, CA) at −70 °C until
use. All animal experiments were approved by the Insti-
tute’s Animal Care and Use Committee.
RNA-Seq analysis
The collected samples were sent to JSC Genoanalytica
(Moscow, Russia) where mRNA was extracted using
Dynabeads mRNA Purification Kit (Ambion, USA).
cDNA libraries were constructed using NEBNext mRNA
Library Prep Reagent Set for Illumina (NEB, USA) fol-
lowing the manufacturer’s protocol and subjected to
single-end sequencing on Illumina HiSeq1500 with read
length of 50 bases. Three hypothalami from ISIAH and
three hypothalami from WAG rats were run as experi-
mental replicates. The resulting fastq-formatted sequen-
cing data were mapped to the RGSC Rnor_5.0\rn5
reference genome using Tophat2 aligner [56] andENSEMBL/RefSeq gene annotation. A quality assess-
ment of the mapped data was performed using the
module ‘CollectRnaSeqMetrics’ from Picard tools suite
(http://broadinstitute.github.io/picard/). The summary
statistics for each sequenced library is given in Additional
file 7. The Cufflinks/Cuffdiff programs were then used to
estimate gene expression levels in FPKM (fragments per
kilobase of transcript per million mapped reads) and to
perform differential expression analysis [57]. Genes were
defined as being expressed if they were assigned to test
status “OK” (i.e., test successful) in the Cufflinks program.
The false discovery rate (FDR) adjusted p-value (q value)
was calculated automatically in Cuffdiff program. Genes
were considered to be differentially expressed at an FDR q
value < 0.05. Although the used Cufflinks pipeline in-
cluded the reference-guided assembly stage, only known
annotations were used in the following analysis. The
RNA-Seq data were deposited in the NCBI Short Read
Archive database with Accession number: PRJNA299102.
Functional annotation
The functional analysis of DEGs (see Additional file 1)
was performed using the DAVID (The Database for
Annotation, Visualization and Integrated Discovery) tool
(http://david.abcc.ncifcrf.gov/) [58, 59]. The Rattus nor-
vegicus genome was used as the background list for the
over-representation analysis in DAVID. The GO option
was utilized, and the significantly (p < 0.05) enriched
biological processes and groups of genes possibly con-
tributing to hypertensive phenotype in ISIAH rats were
identified. The Kyoto Encyclopedia of Genes and Genomes
Pathway Database (KEGG, http://www.genome.jp/kegg/)
was used to identify pathways that were most significant to
the data set. The genes related to hypertension and CNS
diseases were detected according to the DEGs annotation
in Rat Genome Database (RGD, http://rgd.mcw.edu/). The
detection of transcription factors among DEGs was
performed using gene annotations from GenBank
(http://www.ncbi.nlm.nih.gov/gene/), an atlas of com-
binatorial transcriptional regulation in mouse and
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Quantitative real-time PCR (qPCR)
The relative amount of target mRNA was measured by
qPCR. Hypothalami were analyzed in 3-month old
ISIAH and WAG rats (13 animals in each group). Total
RNA was extracted using the TRI reagent (Molecular re-
search center, USA). Remaining traces of genomic DNA
were removed from the RNA samples using DNase I
(Promega, USA) treatment, according to the manufac-
turer’s instructions.
cDNA was synthesized using 3 μg of total RNA,
0.25 nmol of random nonanucleotide primers (Biosan,
Russia), 36 μl of reverse transcription buffer, 40 units of
MoMLV (Vektor-Best, RF), and 0.4 mM dNTP. The
cDNA was synthesized at 37 °C (1 h), 42 °C (30 min),
and 50 °C (10 min). The enzyme was inactivated by
heating the mixture at 75 °C for 5 min.
qPCR was performed in a final volume of 20 μl. The
reaction volume contained a master mix with SYBR
Green, forward and reverse primers (0.15 mM each), 1
unit of HotStart Taq polymerase (Vektor-Best, RF), and
the cDNA template. The housekeeping gene Rpl30 en-
coding ribosomal protein L30 was used as a reference
gene. Primer sequences are given in Additional file 8.
qPCR was carried out in an iCycler iQ4 Real-Time
PCR Detection System (Bio-Rad Laboratories, USA) with
an initial denaturation of 1 min at 95 °C followed by
35 cycles of 15 s at 95 °C, 20 s at each primer’s annealing
temperatures (see Additional file 8), 20 s at 72 °C, fluor-
escence signal acquisition for 10 s at 83 °C and gener-
ation of the melting curve from 65 °C to 94 °C. The
standard-curve quantitation method was applied [61].
Standard cDNA solution for plotting calibration curves
was obtained by mixing aliquots from each of the syn-
thesized cDNA samples. In each experiment, cDNA
samples with primers for the target gene (three repli-
cates per cDNA sample), the same samples with primers
for the reference gene (three replicates), and the stand-
ard cDNA dilutions (1 : 4, 1 : 8, 1 : 16, and 1 : 32) with
the primers for the target gene (two replicates) and with
the primers for the reference gene (two replicates) were
placed on the same plate. The relative amount of the
tested cDNA was determined using calibration curves de-
rived from the dilutions of the standard cDNA. Calibra-
tion curves were built using iCycler iQ4 Real-Time PCR
Detection System software. The value for the target gene
was further normalized against the qPCR level of the ref-
erence gene. The relative mRNA abundance was calcu-
lated as a ratio of the normalized (mRNA/Rpl30) mRNA
level in the experimental ISIAH samples to the normal-
ized (mRNA/Rpl30) mRNA level in the control WAG
samples. The normalized mRNA level in the controlsamples of the WAG rats was assigned a value of 1. The
data points that did not fit a normal distribution (assessed
by 3-sigma limits) were removed from the analysis.
Statistical methods
Statistical calculations for qPCR data were performed
with the software package Statistica v.6.0 (Statsoft, USA)
using Student’s t-test. Differences were considered statis-
tically significant at p < 0.05. The data were presented as
the means and their standard errors (M ± S.E.M.).
The acquired RNA-seq data (FPKM values) were log
transformed, centered and normalized. The principal co-
ordinates method based on Euclidean metric distances
was used for scaling the data sets. Then, the partial-least
squares discriminant analysis (PLS-DA) approach was
used to explore the pattern of co-variation for linear
combinations between two blocks of variables [62, 63].
In the current experiment, the PLS-DA method and
Pearson correlation were used to find a set of variables
(expressed genes) that maximize the covariance between
gene expression in two strains and fixed matrix with
contrast values 1 and −1 for ISIAH rats and WAG rats,
correspondingly. These procedures helped to construct
the PLS-DA Axes maximizing the distances between
ISIAH and WAG rats and to define the correlation be-
tween gene expression and PLS-DA Axis 1. The genes
showing the most deviation along the first functionally
meaningful synthetic PLS-DA Axis were considered to be
genes that contribute the most to inter-strain differences.
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